Tripterygium-derived celastrol inhibits 5-HT3A receptors via key residue interactions: A comparative electrophysiological and docking study
- PMID: 40381881
- DOI: 10.1016/j.neulet.2025.138265
Tripterygium-derived celastrol inhibits 5-HT3A receptors via key residue interactions: A comparative electrophysiological and docking study
Abstract
This study examines the effects of three Tripterygium wilfordii compounds-celastrol, triptolide, and triptonide-on 5-HT3A receptors. Using two-electrode voltage-clamp recordings, we found all three compounds reversibly and concentration-dependently inhibited 5-HT-induced inward currents (I5-HT), with celastrol showing the strongest inhibition (∼83 % at 100 µM) compared to triptolide (∼40 %) and triptonide (∼30 %) at 300 µM. Their voltage- and use-independent inhibition suggests they are not open-channel blockers. Further molecular docking and mutational analysis revealed celastrol binds to K127 and Y114, with mutations at these sites significantly reducing its inhibitory effect. Overall, celastrol, triptolide, and triptonide may suppress hyperactive gut signaling via 5-HT3A inhibition, with celastrol emerging as a promising therapeutic candidate.
Keywords: 5-HT3A receptor; Celastrol; Tripterygium wilfordii Hook F; Triptolide; Triptonide.
Copyright © 2025 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Subtype-selective effect and molecular regulation of celastrol and triptolide at human nicotinic acetylcholine receptors.Chem Biol Interact. 2025 Feb 25;408:111412. doi: 10.1016/j.cbi.2025.111412. Epub 2025 Feb 4. Chem Biol Interact. 2025. PMID: 39914504
-
A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes.Biomed Pharmacother. 2023 Jun;162:114705. doi: 10.1016/j.biopha.2023.114705. Epub 2023 Apr 14. Biomed Pharmacother. 2023. PMID: 37062220 Review.
-
Therapeutic targets of thunder god vine (Tripterygium wilfordii hook) in rheumatoid arthritis (Review).Mol Med Rep. 2020 Jun;21(6):2303-2310. doi: 10.3892/mmr.2020.11052. Epub 2020 Apr 2. Mol Med Rep. 2020. PMID: 32323812 Review.
-
Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.Oncotarget. 2015 Oct 20;6(32):32790-804. doi: 10.18632/oncotarget.5411. Oncotarget. 2015. PMID: 26447544 Free PMC article.
-
Antiangiogenic activity of Tripterygium wilfordii and its terpenoids.J Ethnopharmacol. 2009 Jan 12;121(1):61-8. doi: 10.1016/j.jep.2008.09.033. Epub 2008 Oct 18. J Ethnopharmacol. 2009. PMID: 18996177
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources